Dividend IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share. IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share.
Dividend IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share. IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share.
Dividend IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share. IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share.
Corp Action Recommendation of Dividend Recommendation of Dividend
Corp Action Recommendation of Dividend Recommendation of Dividend
Corp Action Recommendation of Dividend Recommendation of Dividend
Outcome of Board Meeting IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Ipca Laboratories (IPCALAB) has made the transcript of its latest earnings conference call available on the NSE exchange. Investors can review management insights.
Ipca Laboratories held its Q4 FY26 earnings conference call on June 1, 2026. Management shared insights on financial performance, operational updates, and future strategy.
IPCA LABORATORIES Q3 FY25 Results
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.